Health and Happiness (H&H) International Holdings Limited

DB:8BI Stock Report

Market Cap: €718.1m

Health and Happiness (H&H) International Holdings Valuation

Is 8BI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 8BI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 8BI (€1.06) is trading below our estimate of fair value (€5.3)

Significantly Below Fair Value: 8BI is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 8BI?

Key metric: As 8BI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 8BI. This is calculated by dividing 8BI's market cap by their current earnings.
What is 8BI's PE Ratio?
PE Ratio19.5x
EarningsCN¥279.63m
Market CapCN¥5.44b

Price to Earnings Ratio vs Peers

How does 8BI's PE Ratio compare to its peers?

The above table shows the PE ratio for 8BI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average10.1x
SSH Südwestdeutsche Salzwerke
15xn/a€609.4m
NLM FRoSTA
12xn/a€415.6m
SZU Südzucker
6.7x-10.2%€2.2b
SMB Schwälbchen Molkerei Jakob Berz
6.7xn/a€55.8m
8BI Health and Happiness (H&H) International Holdings
19.5x39.0%€5.9b

Price-To-Earnings vs Peers: 8BI is expensive based on its Price-To-Earnings Ratio (19.5x) compared to the peer average (10.1x).


Price to Earnings Ratio vs Industry

How does 8BI's PE Ratio compare vs other companies in the European Food Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
8BI 19.5xIndustry Avg. 13.4xNo. of Companies19PE0816243240+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 8BI is expensive based on its Price-To-Earnings Ratio (19.5x) compared to the European Food industry average (13.5x).


Price to Earnings Ratio vs Fair Ratio

What is 8BI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

8BI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.5x
Fair PE Ratio31.2x

Price-To-Earnings vs Fair Ratio: 8BI is good value based on its Price-To-Earnings Ratio (19.5x) compared to the estimated Fair Price-To-Earnings Ratio (31.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 8BI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.06
€1.34
+26.2%
10.9%€1.61€1.20n/a10
Nov ’25€1.13
€1.33
+17.7%
11.9%€1.59€1.18n/a10
Oct ’25€1.24
€1.30
+5.2%
13.1%€1.57€1.05n/a10
Sep ’25€0.92
€1.35
+47.1%
18.2%€1.95€1.05n/a10
Aug ’25€0.94
€1.54
+62.8%
13.1%€1.95€1.24n/a10
Jul ’25€0.99
€1.61
+61.4%
13.2%€1.96€1.25n/a10
Jun ’25€1.18
€1.69
+43.5%
19.2%€2.52€1.23n/a12
May ’25€1.18
€1.71
+45.3%
19.2%€2.55€1.25n/a12
Apr ’25€1.20
€1.74
+44.6%
18.7%€2.55€1.25n/a12
Mar ’25€1.34
€1.84
+37.6%
21.9%€3.06€1.36n/a13
Feb ’25€1.19
€1.84
+54.9%
21.9%€3.06€1.36n/a13
Jan ’25€1.36
€1.84
+34.9%
23.8%€3.05€1.26n/a13
Dec ’24€1.24
€1.86
+49.6%
23.6%€3.08€1.29n/a13
Nov ’24€1.28
€1.89
+47.9%
22.8%€3.10€1.30€1.1314
Oct ’24€1.13
€1.85
+64.0%
23.3%€3.06€1.28€1.2415
Sep ’24€1.14
€1.79
+57.4%
18.8%€2.48€1.27€0.9215
Aug ’24€1.19
€1.83
+54.2%
19.6%€2.52€1.27€0.9415
Jul ’24€1.12
€1.90
+70.0%
18.3%€2.54€1.28€0.9915
Jun ’24€1.18
€1.97
+66.8%
16.1%€2.64€1.50€1.1815
May ’24€1.50
€1.95
+29.9%
16.1%€2.62€1.49€1.1815
Apr ’24€1.48
€1.92
+29.7%
18.2%€2.68€1.40€1.2015
Mar ’24€1.60
€2.14
+34.0%
19.4%€2.89€1.48€1.3413
Feb ’24€1.71
€2.13
+24.9%
18.8%€2.85€1.46€1.1913
Jan ’24€1.94
€1.74
-10.1%
30.4%€2.86€1.24€1.3613
Dec ’23€1.21
€1.71
+41.1%
38.1%€3.33€1.14€1.2413
Nov ’23€0.93
€1.77
+90.6%
36.1%€3.41€1.19€1.2814

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies